Lawrence K. Cohen
6Patents
6h-index
13Co-inventors
56Inventor score
Filing activity: Aug 26, 1988 → May 22, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5674722A | Genetic modification of endothelial cells | Emerging Cross-Sectional Technologies | 46 | Expired |
| US5093258A | Recombinant fowlpox virus and recombination vector | Chemistry; Metallurgy | 35 | Expired |
| US6936243B2 | Adeno-associated viral vector-mediated delivery of DNA to cells of the liver | Chemistry; Metallurgy | 26 | Expired |
| US6140111A | Retroviral gene therapy vectors and therapeutic methods based thereon | Chemistry; Metallurgy | 15 | Expired |
| US6001350A | Genetic modification of endothelial cells | Chemistry; Metallurgy | 9 | Expired |
| US6544771B1 | Retroviral gene therapy vectors and therapeutic methods based thereon | Chemistry; Metallurgy | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.